Pulmatrix (PULM) Other Operating Expenses (2016 - 2024)

Pulmatrix (PULM) posted Other Operating Expenses of $2.6 million for Q2 2024, down 26.81% sequentially from $3.6 million in Q3 2021.

Pulmatrix (PULM) Other Operating Expenses (2016 - 2024) Analysis & Trends

Pulmatrix has reported Other Operating Expenses for 4 years, with the latest figure at $2.6 million in Q2 2024.

Quarterly Other Operating Expenses changed N/A year-over-year to $2.6 million in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $2.6 million (changed N/A YoY) and the FY2024 annual result came in at $2.6 million, changed N/A from the prior year.
Other Operating Expenses fell to $2.6 million in Q2 2024 per PULM's latest filing, from $3.6 million in the prior quarter.
Over five years, Other Operating Expenses peaked at $3.6 million in Q3 2021 and troughed at $2.6 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Pulmatrix	5.46 Mn	5.46 Mn	-

Download Data